Unknown

Dataset Information

0

?-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.


ABSTRACT: Inhibition of novel biological pathways in Mycobacterium tuberculosis (Mtb) creates the potential for alternative approaches for treating drug-resistant tuberculosis. In vitro studies have shown that dithiocarbamate-derived ?-carbonic anhydrase (?-CA) inhibitors Fc14-594?A and Fc14-584B effectively inhibit the activity of Mtb ?-CA enzymes. We screened the dithiocarbamates for toxicity, and studied the in vivo inhibitory effect of the least toxic inhibitor on M. marinum in a zebrafish model. In our toxicity screening, Fc14-584B emerged as the least toxic and showed minimal toxicity in 5-day-old larvae at 300?µM concentration. In vitro inhibition of M. marinum showed that both compounds inhibited growth at a concentration of 75?µM. In vivo inhibition studies using 300?µM Fc14-584B showed significant (p?>?.05) impairment of bacterial growth in zebrafish larvae at 6?days post infection. Our studies highlight the therapeutic potential of Fc14-584B as a ?-CA inhibitor against Mtb, and that dithiocarbamate compounds may be developed into potent anti-tuberculosis drugs.

SUBMITTER: Aspatwar A 

PROVIDER: S-EPMC6445161 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.

Aspatwar Ashok A   Hammarén Milka M   Koskinen Sanni S   Luukinen Bruno B   Barker Harlan H   Carta Fabrizio F   Supuran Claudiu T CT   Parikka Mataleena M   Parkkila Seppo S  

Journal of enzyme inhibition and medicinal chemistry 20171201 1


Inhibition of novel biological pathways in Mycobacterium tuberculosis (Mtb) creates the potential for alternative approaches for treating drug-resistant tuberculosis. In vitro studies have shown that dithiocarbamate-derived β-carbonic anhydrase (β-CA) inhibitors Fc14-594 A and Fc14-584B effectively inhibit the activity of Mtb β-CA enzymes. We screened the dithiocarbamates for toxicity, and studied the in vivo inhibitory effect of the least toxic inhibitor on M. marinum in a zebrafish model. In o  ...[more]

Similar Datasets

| S-EPMC7775894 | biostudies-literature
| S-EPMC6044661 | biostudies-literature
| S-EPMC4813232 | biostudies-literature
| S-EPMC4833128 | biostudies-other
| S-EPMC5542985 | biostudies-literature
| S-EPMC5342526 | biostudies-literature
| S-EPMC5343876 | biostudies-literature
| S-EPMC2699117 | biostudies-literature
| S-EPMC5530262 | biostudies-other
| S-EPMC7000172 | biostudies-literature